Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Gets ISO Accreditation for CupPrint

NEW YORK (GenomeWeb News) - Agendia has acquired ISO/IEC 17025:2005 accreditation for its CupPrint microarray service from the Dutch Accreditation Council, the company said today.
 
The company was granted ISO 17025 accreditations for MammaPrint, a microarray-based breast cancer diagnostic, in Sept. 2005. According to Agendia, it is the first company to receive this accreditation for the test.
 
CupPrint is a test for cancer of unknown primary.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more